Skip to main content

Patents

Patents

Patents and Technology transfer to Industry:

The faculty members of the School have close interaction with the Industry providing consultancy to the industry. SBT holds the privilege of being the first University Department of Biotechnology to have transferred several technologies in the area of biotechnology, that are at advanced stages of commercialization with many more in the pipeline.

 

Patents:

  • R. Bhatnagar (2001-2002). A Process for the Preparation of Non-Toxic Anthrax Vaccine. Indian patent (1222/Del/2001) accepted.  International PCT application  (PCT/IN2002/00048; WO-03-048390A1, June 12,  2003) published. 
  • R.  Bhatnagar (2001). A process for constitutively preparing anthrax protective antigen. Indian patent (1127/Del/2001) accepted.
  • R.  Bhatnagar (2001). An Anthrax Protective Antigen. Indian patent (1074/Del/2002)  accepted.
  • R.  Bhatnagar (2001). High Level Constitutive Production of Anthrax Protective Antigen. International  PCT application (PCT/IN01/00215; WO-03-040179A1, 15 May 2003) published.
  • R. Bhatnagar  (2005). Transformation of an edible crop with paga Gene of Bacillus Anthracis. Indian patent application (2078/DEL/2005) filed.
  •  R. Bhatnagar (2007, 2008). Insecticidal XnGroEL protein from Xenorhabdus  nematophila Indian Patent (1092/DEL/2007)  and International PCT (PCT/IN2008/000316) applications  filed.
  •  R. Bhatnagar  (2007, 2008). DNA vaccine against Anthrax. Indian patent (2355/DEL/2007) and International PCT (PCT/IN2008/000761) applications  filed.
  • Aparna Dixit (2007). Anti-diabetic recombinant protein. Indian patent and International PCT applications  filed.
  • Aparna Dixit (2007). Recombinant vaccine against Aeromonas hydrophila. Indian Patent application filed.
  • R. Bhatnagar (2008). An immunodominant B cell epitope based protein vaccine against Anthrax. Indian Patent application (2947/DEL/2008) filed.
  • R. Bhatnagar (2008). A pharmaceutical composition of vaccine against Rabies…..its preparation thereof. Indian Patent (1449/DEL/2008) and International PCT (PCT/IN2008/000578) applications filed.  
  • K. J. Mukherjee (2006). A process for getting high yields of xylanases (patent application filed).
  • K.J. Mukherjee (1999). A process for getting high yields of streptokinase.
  • K.J. Mukherjee (2002). Process technology for production of human alpha interferon in E.coli Application No. 212080 (1276/Del/2002) Indian Patent Accepted.
  • Santosh K. Kar, (2006). Method for Identification and/or Diagnosis of REM Sleep Loss from Blood Samples. Indian Patent. Date of Issue: 24 Oct 2006.
  • Patent No.7125724.

 

Transfer of Technologies:

Technology for recombinant vaccine against anthrax has been transferred to Panacea  Biotech, New Delhi (Rakesh Bhatnagar).

Technology for “Streptokinase production” has been transferred to Shanta Biotechnics Pvt. Ltd. Hyderabad. The product has been launched in the market in 2004 (K.J. Mukherjee).

Technology for “alpha interferon production” transferred to Ms Shasun Chemicals Chennai. (K.J. Mukherjee).

Technology for Xylanases production transferred to BCIL for licensing to industry (K.J. Mukherjee).

Technology for recombinant human GM-CSF and other therapeutic proteins to be transferred to Indo-Bioactive Pvt. Ltd., Pune (in process)  (K.J. Mukherjee).

A warm welcome to the modified and updated website of the Centre for East Asian Studies. The East Asian region has been at the forefront of several path-breaking changes since 1970s beginning with the redefining the development architecture with its State-led development model besides emerging as a major region in the global politics and a key hub of the sophisticated technologies. The Centre is one of the thirteen Centres of the School of International Studies, Jawaharlal Nehru University, New Delhi that provides a holistic understanding of the region.

Initially, established as a Centre for Chinese and Japanese Studies, it subsequently grew to include Korean Studies as well. At present there are eight faculty members in the Centre. Several distinguished faculty who have now retired include the late Prof. Gargi Dutt, Prof. P.A.N. Murthy, Prof. G.P. Deshpande, Dr. Nranarayan Das, Prof. R.R. Krishnan and Prof. K.V. Kesavan. Besides, Dr. Madhu Bhalla served at the Centre in Chinese Studies Programme during 1994-2006. In addition, Ms. Kamlesh Jain and Dr. M. M. Kunju served the Centre as the Documentation Officers in Chinese and Japanese Studies respectively.

The academic curriculum covers both modern and contemporary facets of East Asia as each scholar specializes in an area of his/her interest in the region. The integrated course involves two semesters of classes at the M. Phil programme and a dissertation for the M. Phil and a thesis for Ph. D programme respectively. The central objective is to impart an interdisciplinary knowledge and understanding of history, foreign policy, government and politics, society and culture and political economy of the respective areas. Students can explore new and emerging themes such as East Asian regionalism, the evolving East Asian Community, the rise of China, resurgence of Japan and the prospects for reunification of the Korean peninsula. Additionally, the Centre lays great emphasis on the building of language skills. The background of scholars includes mostly from the social science disciplines; History, Political Science, Economics, Sociology, International Relations and language.

Several students of the centre have been recipients of prestigious research fellowships awarded by Japan Foundation, Mombusho (Ministry of Education, Government of Japan), Saburo Okita Memorial Fellowship, Nippon Foundation, Korea Foundation, Nehru Memorial Fellowship, and Fellowship from the Chinese and Taiwanese Governments. Besides, students from Japan receive fellowship from the Indian Council of Cultural Relations.